MedCap

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, MedCap had revenue of €49.98M and net profit of €7.48M

(EUR)	September 2026	YoY
Revenue	49.98M	10.17%
Gross profit	7.89M	22.07%
Net profit	7.48M	61.47%
EBITDA	11.94M	18.50%

Fundamentals

Metric	Value
Market capitalization	€755.4M
Number of shares	14.98M
52-week high/low	€56.74 - €40.13
Dividends	No
Beta	0.47
P/E ratio	30.25
PEG ratio	0.78
P/B ratio	4.85
P/S ratio	3.57

Company profile

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe. It typically invests between SEK25 million ($2.75 million) to SEK150 million ($16.51 million) with enterprise value and sales revenue between SEK50 million ($5.90 million) to SEK200 million ($23.06 million) and EBITDA between SEK1 million ($0.11 million) to SEK50 million ($5.50 million). The firm seeks to acquire stakes between 20% and 50% in its portfolio companies. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.